Sunshine Biopharma, Inc. (SBFM) shares are surging more than 86 percent on Monday morning trade after the company reported a narrower loss for the full year on an increase in revenue, and an absence of one-time charges compared to the prior year.
The fullyear loss was $26.744 million or $0.19 per share, compared to loss of $4.51 million or $1.76 per share, a year ago. In the prior year the company had recorded a one-time goodwill write-off.
Sales for the period increased to $24.09 million from $4.345 million last year.
Currently, shares are at $0.11, up 85.95 percent from the previous close of $0.06 on a volume of 166,412,248.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.